Biotechnomy and the Three Zero Theory: A Blueprint for Sustainable Growth

preprint OA: closed CC-BY-4.0
AI-generated deep summary by claude@2026-07, 2026-07-06 · read from full text

The provided text contains only bibliographic boilerplate and license information, with no description of study aims, methods, results, or conclusions. There are no details about the population, experimental or analytical approach, outcomes measured, or any limitations stated in the excerpt. Because the substantive content of the paper is missing from the input, a research summary cannot be constructed from what is shown. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Integrating biotechnomy with Dr. Muhammad Yunus's Three-Zero Theory offers a sustainable development path for developing countries. Biotechnomy uses local biological resources to create value-added, sustainable products, addressing various sectors. Post-COVID-19, biotechnology's role has expanded, enhancing healthcare, agriculture, and environmental management. The Three-Zero Theory highlights youth involvement, technological innovation, effective governance, and social entrepreneurship. This movement can generate jobs, reduce unemployment, and achieve zero carbon emissions. However, challenges like inadequate infrastructure, investment needs, regulatory hurdles, and ethical concerns must be addressed. To implement these strategies, academics, researchers, scholars, and policymakers must think creatively and advocate for swift government action. A strategic approach is essential to align economic development with environmental sustainability and social equity, fostering growth and prosperity.
Full text 621 characters · extracted from oa-doi-fallback · click to expand
There is a newer version available for this {{ publicationType }}. View latest version {{ publication.field_name }} {{ publication.subfield_name }} Copyright: © {{ publicationYear }} {{ publication.presentation_authors[0].full_name + (publication.presentation_authors.length > 1 ? ' et al' : '') }}. This is an open access publication distributed under the terms of the CC BY 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Check the {{ publicationType | capitalize }} Source for copyright and license information. Listen on

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-4.0